For the Inventor, By the Inventor

Enter assignee name

Rehovot, Israel

Rosetta Genomics Ltd.

USPTO Granted Patents = 64

CIPO Patents = 9

EPO Patents = 9

Forward Citations = 1,206

Loading Chart...

Loading Chart...

57 inventors (with patents filed for the assignee):

Itzhak Bentwich (29 out of 29 patents)

Ranit Aharonov (19 out of 26 patents)

Amir Avniel (19 out of 28 patents)

4. Yael Karov (15 out of 19 patents)

5. Noga Yerushalmi (8 out of 10 patents)

6. Nitzan Rosenfeld (8 out of 9 patents)

7. Shai Rosenwald (8 out of 8 patents)

8. Ayelet Chajut (8 out of 8 patents)

9. C Frank Bennett (6 out of 201 patents)

10. Christine Esau (6 out of 14 patents)

11. Eric G Marcusson (6 out of 31 patents)

12. Hila Benjamin (5 out of 5 patents)

13. Yael Spector (5 out of 5 patents)

14. Gila Lithwick Yanai (4 out of 4 patents)

15. Shlomit Gilad (3 out of 3 patents)

Core Competencies:

MicroRNAs

Cancer Prognosis

Liver Cancer Treatment

Ovarian Cancer

Gene Expression Signature

Lung Cancer Classification

Heart Failure Diagnosis

Mesothelioma

Nucleic Acids

Hematopoietic Malignancies

Viral Infections

Tumor Classification

64 patents: Sort by Forward Citations

1. 10301627 - Targeting microRNAs for the treatment of liver cancer (2019-05-28),

2. 9988690 - Compositions and methods for prognosis of ovarian cancer (2018-06-05),

3. 9920379 - Nucleic acids related to MiR-29B-1-5P and uses thereof (2018-03-20),

4. 9914972 - Methods for lung cancer classification (2018-03-13),

5. 9890382 - Nucleic acid compositions related to MIR-138-1-3P and uses thereof (2018-02-13),

6. 9845470 - Targeting microRNAS for the treatment of liver cancer (2017-12-19),

7. 9834821 - Diagnosis and prognosis of various types of cancers (2017-12-05),

8. 9803247 - MicroRNAs expression signature for determination of tumors origin (2017-10-31),

9. 9765334 - Compositions and methods for prognosis of gastric cancer (2017-09-19),

10. 9708667 - MiRNA expression signature in the classification of thyroid tumors (2017-07-18),

11. 9650680 - MicroRNAs and uses thereof (2017-05-16),

12. 9650679 - HSA-MIR-146B-5P-related nucleic acids and uses thereof (2017-05-16),

13. 9631236 - Methods and compositions for determining heart failure or a risk of heart failure (2017-04-25),

14. 9624556 - Viral and viral associated miRNAs and uses thereof (2017-04-18),

15. 9540695 - Compositions and methods for prognosis of ovarian cancer (2017-01-10),

Rosetta Genomics is a leading developer and provider of high-quality molecular diagnostics and personalized medicine solutions. The company focuses on developing and commercializing a wide range of diagnostic tests that enable healthcare professionals to make better informed treatment decisions. With a strong portfolio of proprietary diagnostic platforms and technologies, Rosetta Genomics is dedicated to improving patient care and outcomes in oncology and other areas of medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

64 Patents

#6 in Rehovot

#81 in Israel

#11,009 in the World

Rehovot, Israel

Rosetta Genomics Ltd.

Forward Citations = 1,206

57 inventors:

Itzhak Bentwich (29 out of 29 patents)

Ranit Aharonov (19 out of 26 patents)

Amir Avniel (19 out of 28 patents)

4. Yael Karov (15 out of 19 patents)

5. Noga Yerushalmi (8 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…